Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,101 to 2,120 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| RACK1 receptor for activated C kinase 1 | 10399 HGNC:4399 | 1 | 61 | 0 | 0 | 1,893 | 3,110 |
| CLTC clathrin heavy chain | 1213 HGNC:2092 | 1 | 80 | 0 | 0 | 2,119 | 3,108 |
| EPHA1 EPH receptor A1 | 2041 HGNC:3385 | 1 | 33 | 1 | 97 | 2,640 | 3,104 |
| HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 | 3290 HGNC:5208 | 1 | 58 | 7 | 11 | 1,239 | 3,100 |
| XRCC4 X-ray repair cross complementing 4 | 7518 HGNC:12831 | 1 | 46 | 0 | 0 | 1,847 | 3,098 |
| ATG3 autophagy related 3 | 64422 HGNC:20962 | 1 | 27 | 0 | 0 | 1,439 | 3,097 |
| ATP7A ATPase copper transporting alpha | 538 HGNC:869 | 1 | 19 | 0 | 0 | 1,344 | 3,096 |
| TMPRSS11D transmembrane serine protease 11D | 9407 HGNC:24059 | 1 | 78 | 0 | 0 | 2,153 | 3,095 |
| SATB2 SATB homeobox 2 | 23314 HGNC:21637 | 1 | 61 | 0 | 0 | 2,069 | 3,094 |
| TTK TTK protein kinase | 7272 HGNC:12401 | 1 | 99 | 2 | 2 | 1,509 | 3,094 |
| CEBPD CCAAT enhancer binding protein delta | 1052 HGNC:1835 | 1 | 32 | 0 | 0 | 2,506 | 3,093 |
| RDX radixin | 5962 HGNC:9944 | 1 | 51 | 0 | 0 | 2,051 | 3,092 |
| IGHV3-69-1 immunoglobulin heavy variable 3-69-1 (pseudogene) | 28402 HGNC:5631 | 0 | 0 | 0 | 0 | 1,115 | 3,091 |
| ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 | 5168 HGNC:3357 | 1 | 29 | 1 | 5 | 1,838 | 3,090 |
| MIR96 microRNA 96 | 407053 HGNC:31648 | 0 | 0 | 0 | 0 | 1,269 | 3,090 |
| SERPINH1 serpin family H member 1 | 871 HGNC:1546 | 1 | 160 | 0 | 0 | 1,591 | 3,090 |
| AIP AHR interacting HSP90 co-chaperone | 9049 HGNC:358 | 1 | 6 | 0 | 0 | 1,062 | 3,088 |
| PLEK pleckstrin | 5341 HGNC:9070 | 1 | 41 | 0 | 0 | 2,250 | 3,086 |
| IFITM3 interferon induced transmembrane protein 3 | 10410 HGNC:5414 | 1 | 35 | 0 | 0 | 2,372 | 3,083 |
| DSPP dentin sialophosphoprotein | 1834 HGNC:3054 | 1 | 40 | 0 | 0 | 1,099 | 3,081 |
Code
curl "https://conductscience.org/api/genes/v1?page=106"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=106
{
"data": {
"total": 193990,
"results": [
{
"id": "10399",
"title": "RACK1: receptor for activated C kinase 1",
"summary": "NCBI Gene 10399. 1 protein, 61 patents, 0 drugs, 0 trials, 1,893 NIH grants and 3,110 papers.",
"record": "/library/genes/10399",
"gene_id": 10399,
"symbol": "RACK1",
"name": "receptor for activated C kinase 1",
"hgnc_id": "HGNC:4399",
"counts": {
"proteins": 1,
"patents": 61,
"drugs": 0,
"trials": 0,
"grants": 1893,
"papers": 3110
}
},
{
"id": "1213",
"title": "CLTC: clathrin heavy chain",
"summary": "NCBI Gene 1213. 1 protein, 80 patents, 0 drugs, 0 trials, 2,119 NIH grants and 3,108 papers.",
"record": "/library/genes/1213",
"gene_id": 1213,
"symbol": "CLTC",
"name": "clathrin heavy chain",
"hgnc_id": "HGNC:2092",
"counts": {
"proteins": 1,
"patents": 80,
"drugs": 0,
"trials": 0,
"grants": 2119,
"papers": 3108
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=107",
"request_id": "d-cUGqJy59FE9hWB"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant